Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan
Novartis
Novartis
Jonsson Comprehensive Cancer Center
Novartis
Jonsson Comprehensive Cancer Center
Novartis
Alliance for Clinical Trials in Oncology
Novartis
Novartis
Radboud University Medical Center
Ankara University
Novartis
University of Washington
Novartis
Novartis
Fred Hutchinson Cancer Center
City of Hope Medical Center
Hospices Civils de Lyon
VA Office of Research and Development
University of California, San Francisco
Novartis
University of California, San Francisco
The Netherlands Cancer Institute
OncoC4, Inc.
University of California, San Francisco
Case Comprehensive Cancer Center
Pathos AI, Inc.
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Canadian Cancer Trials Group
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
University College, London
Blue Earth Therapeutics Ltd
Case Comprehensive Cancer Center
University of California, San Francisco
Weill Medical College of Cornell University
Mayo Clinic
CHU de Quebec-Universite Laval
Case Comprehensive Cancer Center
Peter MacCallum Cancer Centre, Australia
Dana-Farber Cancer Institute
Excel Diagnostics and Nuclear Oncology Center
Novartis
Peter MacCallum Cancer Centre, Australia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Maria Sklodowska-Curie National Research Institute of Oncology
European Organisation for Research and Treatment of Cancer - EORTC
Endocyte
UNICANCER
Peter MacCallum Cancer Centre, Australia